| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | [heparan sulfate]-glucosamine N-sulfotransferase activity | 2.90e-04 | 4 | 140 | 2 | GO:0015016 | |
| GeneOntologyMolecularFunction | N-acetylglucosamine deacetylase activity | 2.90e-04 | 4 | 140 | 2 | GO:0050119 | |
| GeneOntologyMolecularFunction | deaminase binding | 2.90e-04 | 4 | 140 | 2 | GO:1990827 | |
| GeneOntologyBiologicalProcess | establishment of planar polarity | 1.14e-05 | 44 | 139 | 5 | GO:0001736 | |
| GeneOntologyBiologicalProcess | establishment of tissue polarity | 1.27e-05 | 45 | 139 | 5 | GO:0007164 | |
| GeneOntologyBiologicalProcess | sulfur oxidation | 4.51e-05 | 2 | 139 | 2 | GO:0019417 | |
| GeneOntologyCellularComponent | actin cytoskeleton | MICAL1 XIRP1 HNRNPCL1 ARSJ RGS22 DYRK1A ADAM8 HNRNPCL3 JUP MICAL2 CORIN BAIAP2 MLPH TNS3 | 3.63e-05 | 576 | 141 | 14 | GO:0015629 |
| GeneOntologyCellularComponent | nuclear protein-containing complex | CDK8 NRIP1 HNRNPCL1 SETD1B RB1 C9orf78 POLR2B INTS1 PCGF3 SAGE2P JMJD1C GATAD2B HNRNPCL3 ORC4 PHC3 JUP GTF2H2 ASXL3 PABPC3 TLE4 SAGE1 SMAD3 | 1.37e-04 | 1377 | 141 | 22 | GO:0140513 |
| GeneOntologyCellularComponent | integrator complex | 3.65e-04 | 21 | 141 | 3 | GO:0032039 | |
| MousePheno | kidney cyst | 1.63e-05 | 177 | 116 | 9 | MP:0003675 | |
| MousePheno | decreased spongiotrophoblast size | 1.97e-05 | 20 | 116 | 4 | MP:0012099 | |
| Pubmed | The in vivo Interaction Landscape of Histones H3.1 and H3.3. | FOXK2 HIVEP1 ZNF146 CENPC RB1 C9orf78 INTS1 CHD9 JMJD1C GATAD2B HIRA ORC4 FBXO38 PHC3 EHMT1 KPNA2 | 4.46e-09 | 608 | 142 | 16 | 36089195 |
| Pubmed | HNRNPCL1 DOCK9 ITGB4 GRSF1 HNRNPCL3 BMP6 PABPC3 GFM1 MLPH ZMYM6 | 1.24e-07 | 259 | 142 | 10 | 9811942 | |
| Pubmed | SEL1L FOXK2 ZNF146 AFTPH PKP4 POLR2B PHRF1 INTS1 DYRK1A ZNF318 ARHGEF11 GRSF1 GATAD2B HIRA EFR3A SLC25A3 ORC4 PHC3 EHMT1 BAIAP2 SPATS2 AGAP1 | 1.93e-07 | 1497 | 142 | 22 | 31527615 | |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | NDST1 SEMA4B PDE4A FOXK2 ARSJ SETD1B DOCK9 INTS1 DYRK1A ARHGEF11 GBA2 ITGB4 HIRA CELSR2 KLHL36 ENTPD2 EHMT1 FLCN | 6.49e-07 | 1105 | 142 | 18 | 35748872 |
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | CDK8 NRIP1 DNAJC13 FOXK2 FRMPD2 CHD9 GRIK2 IDE PCGF3 JMJD1C TTC19 PACS1 GTF2H2 MICAL2 EHMT1 PLCB4 BAIAP2 SPATS2 MLPH CAP2 AGAP1 | 7.34e-07 | 1489 | 142 | 21 | 28611215 |
| Pubmed | Regulation of ovarian function by the TGF-beta superfamily and follistatin. | 1.32e-06 | 6 | 142 | 3 | 12887271 | |
| Pubmed | PDE4A DNAJC13 PKP4 DYRK1A GRIK2 ZNF318 ARMCX4 ARHGEF11 GATAD2B HIRA CELSR2 PABPC3 EHMT1 BAIAP2 SPATS2 CAP2 | 2.21e-06 | 963 | 142 | 16 | 28671696 | |
| Pubmed | Cooperative polarization of MCAM/CD146 and ERM family proteins in melanoma. | DOCK9 PKP4 GPRIN3 ITGA4 EFR3A SLC25A3 PACS1 TAOK3 DAAM2 AGAP1 | 3.72e-06 | 377 | 142 | 10 | 38117590 |
| Pubmed | The protein interaction landscape of the human CMGC kinase group. | CDK8 HNRNPCL1 ZNF146 MARCHF10 RB1 POLR2B DYRK1A JUP GTF2H2 TLE4 BAIAP2 SPATS2 KPNA2 | 5.96e-06 | 695 | 142 | 13 | 23602568 |
| Pubmed | Identification and functional characterization of transcriptional activators in human cells. | NRIP1 FOXK2 HIVEP1 RB1 DYRK1A IDE JMJD1C GATAD2B PHC3 ZNF518B | 5.98e-06 | 398 | 142 | 10 | 35016035 |
| Pubmed | A High-Density Map for Navigating the Human Polycomb Complexome. | FOXK2 HIVEP1 SETD1B RB1 DYRK1A PCGF3 GATAD2B FBXO38 PHC3 EHMT1 ZNF518B | 6.49e-06 | 495 | 142 | 11 | 27705803 |
| Pubmed | Identification of novel Smad2 and Smad3 associated proteins in response to TGF-beta1. | 7.17e-06 | 65 | 142 | 5 | 18729074 | |
| Pubmed | 1.66e-05 | 2 | 142 | 2 | 19703145 | ||
| Pubmed | 1.66e-05 | 2 | 142 | 2 | 19549636 | ||
| Pubmed | Dyrk1a regulates the cardiomyocyte cell cycle via D-cyclin-dependent Rb/E2f-signalling. | 1.66e-05 | 2 | 142 | 2 | 27056896 | |
| Pubmed | 1.66e-05 | 2 | 142 | 2 | 16612335 | ||
| Pubmed | 1.66e-05 | 2 | 142 | 2 | 19112495 | ||
| Pubmed | 1.66e-05 | 2 | 142 | 2 | 19850835 | ||
| Pubmed | 1.66e-05 | 2 | 142 | 2 | 21898381 | ||
| Pubmed | 1.66e-05 | 2 | 142 | 2 | 20362553 | ||
| Pubmed | 1.66e-05 | 2 | 142 | 2 | 30139996 | ||
| Pubmed | 1.66e-05 | 2 | 142 | 2 | 20841369 | ||
| Pubmed | 1.66e-05 | 2 | 142 | 2 | 19454698 | ||
| Pubmed | Energetic evaluation of binding modes in the C3d and Factor H (CCP 19-20) complex. | 1.66e-05 | 2 | 142 | 2 | 25628052 | |
| Pubmed | 1.66e-05 | 2 | 142 | 2 | 21435440 | ||
| Pubmed | 1.66e-05 | 2 | 142 | 2 | 19505474 | ||
| Pubmed | 1.66e-05 | 2 | 142 | 2 | 12695505 | ||
| Pubmed | Alpha4beta1 integrin acts as a cell receptor for murine polyomavirus at the postattachment level. | 1.66e-05 | 2 | 142 | 2 | 12634351 | |
| Pubmed | 1.66e-05 | 2 | 142 | 2 | 23661701 | ||
| Pubmed | 1.66e-05 | 2 | 142 | 2 | 22965878 | ||
| Pubmed | 1.66e-05 | 2 | 142 | 2 | 19503104 | ||
| Pubmed | Oocyte-expressed TGF-beta superfamily members in female fertility. | 1.66e-05 | 2 | 142 | 2 | 10687846 | |
| Pubmed | 1.66e-05 | 2 | 142 | 2 | 39390295 | ||
| Pubmed | Murine osteogenic protein (OP-1): high levels of mRNA in kidney. | 1.66e-05 | 2 | 142 | 2 | 1715687 | |
| Pubmed | Both domain 19 and domain 20 of factor H are involved in binding to complement C3b and C3d. | 1.66e-05 | 2 | 142 | 2 | 20378178 | |
| Pubmed | Differential regulation of actin microfilaments by human MICAL proteins. | 1.66e-05 | 2 | 142 | 2 | 22331357 | |
| Pubmed | 1.66e-05 | 2 | 142 | 2 | 23139756 | ||
| Pubmed | Plakoglobin-dependent regulation of keratinocyte apoptosis by Rnd3. | 1.66e-05 | 2 | 142 | 2 | 22454524 | |
| Pubmed | Structural basis for engagement by complement factor H of C3b on a self surface. | 1.66e-05 | 2 | 142 | 2 | 21317894 | |
| Pubmed | Systemic complement activation in age-related macular degeneration. | 1.66e-05 | 2 | 142 | 2 | 18596911 | |
| Pubmed | 1.66e-05 | 2 | 142 | 2 | 21846488 | ||
| Pubmed | Enhanced BMP signaling results in supernumerary tooth formation in USAG-1 deficient mouse. | 1.85e-05 | 13 | 142 | 3 | 18329379 | |
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | DNAJC13 HIVEP1 AFTPH C9orf78 PHRF1 ZNF318 GATAD2B FBXO38 PACS1 PHC3 LATS1 TLE4 KLHDC4 | 1.86e-05 | 774 | 142 | 13 | 15302935 |
| Pubmed | Regulation of the ovarian reserve by members of the transforming growth factor beta family. | 2.35e-05 | 14 | 142 | 3 | 22847922 | |
| Pubmed | DNAJC13 CENPC PKP4 POLR2B GPRIN3 IDE PTPRU EFR3A FBXO38 PTP4A2 PACS1 BAIAP2 CAP2 TNS3 KPNA2 | 2.72e-05 | 1049 | 142 | 15 | 27880917 | |
| Pubmed | The Tumor Suppressor CIC Directly Regulates MAPK Pathway Genes via Histone Deacetylation. | FOXK2 RB1 POLR2B INTS1 DYRK1A GATAD2B SLC25A3 JUP EHMT1 SMAD3 KPNA2 | 2.95e-05 | 583 | 142 | 11 | 29844126 |
| Pubmed | A direct physical interaction between Nanog and Sox2 regulates embryonic stem cell self-renewal. | 3.16e-05 | 146 | 142 | 6 | 23892456 | |
| Pubmed | 3.48e-05 | 45 | 142 | 4 | 22696295 | ||
| Pubmed | FOXK2 DOCK9 POLR2B DYRK1A ZNF318 ITGB4 GRSF1 ORC4 PACS1 PHC3 JUP TAOK3 GBP4 TLE4 CPLANE1 | 3.96e-05 | 1084 | 142 | 15 | 11544199 | |
| Pubmed | The protomap is propagated to cortical plate neurons through an Eomes-dependent intermediate map. | 4.33e-05 | 94 | 142 | 5 | 23431145 | |
| Pubmed | BMP4 substitutes for loss of BMP7 during kidney development. | 4.95e-05 | 3 | 142 | 2 | 16154126 | |
| Pubmed | 4.95e-05 | 3 | 142 | 2 | 7535292 | ||
| Pubmed | Ultrastructures and interactions of complement factors H and I. | 4.95e-05 | 3 | 142 | 2 | 1401896 | |
| Pubmed | 4.95e-05 | 3 | 142 | 2 | 19899988 | ||
| Pubmed | 4.95e-05 | 3 | 142 | 2 | 19048105 | ||
| Pubmed | 4.95e-05 | 3 | 142 | 2 | 28346732 | ||
| Pubmed | 4.95e-05 | 3 | 142 | 2 | 23365660 | ||
| Pubmed | 4.95e-05 | 3 | 142 | 2 | 19680263 | ||
| Pubmed | 4.95e-05 | 3 | 142 | 2 | 34233521 | ||
| Pubmed | 4.95e-05 | 3 | 142 | 2 | 20093492 | ||
| Pubmed | 4.95e-05 | 3 | 142 | 2 | 19825847 | ||
| Pubmed | 4.95e-05 | 3 | 142 | 2 | 28671664 | ||
| Pubmed | 4.95e-05 | 3 | 142 | 2 | 19823576 | ||
| Pubmed | 4.95e-05 | 3 | 142 | 2 | 1427904 | ||
| Pubmed | Variation in complement factor 3 is associated with risk of age-related macular degeneration. | 4.95e-05 | 3 | 142 | 2 | 17767156 | |
| Pubmed | 4.95e-05 | 3 | 142 | 2 | 27116510 | ||
| Pubmed | 4.95e-05 | 3 | 142 | 2 | 23853066 | ||
| Pubmed | 4.95e-05 | 3 | 142 | 2 | 33536243 | ||
| Pubmed | C3- and CR3-dependent microglial clearance protects photoreceptors in retinitis pigmentosa. | 4.95e-05 | 3 | 142 | 2 | 31209071 | |
| Pubmed | Interaction of uromodulin and complement factor H enhances C3b inactivation. | 4.95e-05 | 3 | 142 | 2 | 27113631 | |
| Pubmed | Fc Gamma Receptors and Complement Component 3 Facilitate Anti-fVIII Antibody Formation. | 4.95e-05 | 3 | 142 | 2 | 32582142 | |
| Pubmed | E2F1 represses beta-catenin transcription and is antagonized by both pRB and CDK8. | 4.95e-05 | 3 | 142 | 2 | 18794899 | |
| Pubmed | 4.95e-05 | 3 | 142 | 2 | 23747511 | ||
| Pubmed | 4.95e-05 | 3 | 142 | 2 | 27855376 | ||
| Pubmed | 4.95e-05 | 3 | 142 | 2 | 35033126 | ||
| Pubmed | 4.95e-05 | 3 | 142 | 2 | 18349123 | ||
| Pubmed | Complement component C3 and risk of age-related macular degeneration. | 4.95e-05 | 3 | 142 | 2 | 19168221 | |
| Pubmed | 4.95e-05 | 3 | 142 | 2 | 32328755 | ||
| Pubmed | 4.95e-05 | 3 | 142 | 2 | 20664795 | ||
| Pubmed | Comparison of surface recognition and C3b binding properties of mouse and human complement factor H. | 4.95e-05 | 3 | 142 | 2 | 16023208 | |
| Pubmed | 4.95e-05 | 3 | 142 | 2 | 27099955 | ||
| Pubmed | 4.95e-05 | 3 | 142 | 2 | 2263636 | ||
| Pubmed | Genetic architecture of human thinness compared to severe obesity. | 4.95e-05 | 3 | 142 | 2 | 30677029 | |
| Pubmed | 4.95e-05 | 3 | 142 | 2 | 17242198 | ||
| Pubmed | The endothelial cell receptor stabilin-2 regulates VWF-FVIII complex half-life and immunogenicity. | 4.95e-05 | 3 | 142 | 2 | 30124466 | |
| Pubmed | 4.95e-05 | 3 | 142 | 2 | 9988761 | ||
| Pubmed | 4.95e-05 | 3 | 142 | 2 | 21555552 | ||
| Pubmed | 4.95e-05 | 3 | 142 | 2 | 36643920 | ||
| Pubmed | 4.95e-05 | 3 | 142 | 2 | 17722066 | ||
| Pubmed | 4.95e-05 | 3 | 142 | 2 | 29888403 | ||
| Pubmed | 4.95e-05 | 3 | 142 | 2 | 21163532 | ||
| Pubmed | 4.95e-05 | 3 | 142 | 2 | 22305102 | ||
| Pubmed | 4.95e-05 | 3 | 142 | 2 | 21402993 | ||
| Pubmed | Interactions between human complement components factor H, factor I and C3b. | 4.95e-05 | 3 | 142 | 2 | 9291131 | |
| Pubmed | 4.95e-05 | 3 | 142 | 2 | 28434979 | ||
| Pubmed | Susceptibility genes and progression in age-related maculopathy: a study of single eyes. | 4.95e-05 | 3 | 142 | 2 | 19797206 | |
| Pubmed | 4.95e-05 | 3 | 142 | 2 | 28095095 | ||
| Pubmed | 4.95e-05 | 3 | 142 | 2 | 23356914 | ||
| Pubmed | 4.95e-05 | 3 | 142 | 2 | 30253188 | ||
| Pubmed | Proteomic analyses reveal distinct chromatin-associated and soluble transcription factor complexes. | FOXK2 RB1 DYRK1A QRICH1 JMJD1C GATAD2B HIRA TTLL7 ORC4 TLE4 PRDM6 SMAD3 KPNA2 | 5.30e-05 | 857 | 142 | 13 | 25609649 |
| Interaction | H3C3 interactions | FOXK2 HIVEP1 ZNF146 CENPC RB1 C9orf78 ITGA4 JMJD1C GATAD2B HIRA ORC4 FBXO38 PHC3 EHMT1 KPNA2 | 1.58e-06 | 495 | 138 | 15 | int:H3C3 |
| Interaction | DCANP1 interactions | 7.53e-06 | 19 | 138 | 4 | int:DCANP1 | |
| GeneFamily | Armadillo repeat containing|Protein phosphatase 1 regulatory subunits | 8.86e-05 | 43 | 99 | 4 | 409 | |
| GeneFamily | Zinc fingers C2H2-type|Lysine methyltransferases|PR/SET domain family | 8.42e-04 | 34 | 99 | 3 | 487 | |
| GeneFamily | Bone morphogenetic proteins|Astacins | 1.58e-03 | 11 | 99 | 2 | 455 | |
| GeneFamily | G protein-coupled receptors, Class F frizzled | 1.58e-03 | 11 | 99 | 2 | 286 | |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_DN | CDK8 NRIP1 DNAJC13 FOXK2 HIVEP1 CENPC RB1 DOCK9 PKP4 POLR2B DYRK1A CHD9 SPG11 HIRA EFR3A TDRD7 TAOK3 MICAL2 TLE4 PLCB4 OSMR CAP2 SMAD3 AGAP1 | 2.79e-11 | 856 | 140 | 24 | M4500 |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_COMMON_DN | CDK8 NRIP1 DNAJC13 FOXK2 HIVEP1 RB1 PKP4 DYRK1A CHD9 HIRA TDRD7 TLE4 CAP2 SMAD3 AGAP1 | 3.22e-08 | 466 | 140 | 15 | M13522 |
| Coexpression | GENTILE_UV_HIGH_DOSE_DN | CDK8 NRIP1 ZNF146 PKP4 DYRK1A PCGF3 RND3 TLE4 FZD2 SMAD3 KPNA2 | 4.66e-07 | 289 | 140 | 11 | M13630 |
| Coexpression | DAZARD_RESPONSE_TO_UV_NHEK_DN | NRIP1 ZNF146 CENPC DOCK9 DYRK1A CHD9 ZNF318 MICAL2 TLE4 SMAD3 | 5.14e-06 | 300 | 140 | 10 | M8702 |
| Coexpression | DAZARD_UV_RESPONSE_CLUSTER_G6 | 1.33e-05 | 145 | 140 | 7 | M1810 | |
| Coexpression | GENTILE_UV_RESPONSE_CLUSTER_D6 | 3.59e-05 | 35 | 140 | 4 | M15187 | |
| Coexpression | GSE4590_LARGE_PRE_BCELL_VS_VPREB_POS_LARGE_PRE_BCELL_UP | 4.31e-05 | 174 | 140 | 7 | M6877 | |
| Coexpression | SCHAEFFER_PROSTATE_DEVELOPMENT_AND_CANCER_BOX4_DN | 4.49e-05 | 37 | 140 | 4 | MM570 | |
| CoexpressionAtlas | DevelopingGonad_e18.5_epididymis_emap-13166_top-relative-expression-ranked_1000 | CFH NRIP1 DNAJC13 ARSJ PKP4 FRMPD2 CHD9 ITGA4 JMJD1C BMP6 ASXL3 SLIT3 PKHD1 C3 EGFLAM CPLANE1 CRISPLD1 AGAP1 | 5.42e-06 | 799 | 140 | 18 | gudmap_developingGonad_e18.5_epididymis_1000 |
| ToppCell | facs-Lung-18m-Endothelial-arterial_endothelial-pulmonary_artery_endothelial_cell-pulmonary_artery_endothelial_cell_l25|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.13e-07 | 180 | 141 | 8 | 67c5068b660cd5e727a665cefe3bd5f8ae887221 | |
| ToppCell | droplet-Lung-nan-18m-Endothelial-Artery_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.58e-07 | 188 | 141 | 8 | 405efea75233ecf70f7d19b630230798d817b7f2 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_epithelium-respiratory_basal_cell-Basal_resting-Basal_resting_L.0.0.0.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.34e-07 | 198 | 141 | 8 | fc00cb25cdc6c31b7f9d397bc9f9a8f4e9708003 | |
| ToppCell | Bronchial-NucSeq-Stromal-Fibroblastic-Fibro_peribronchial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.53e-07 | 200 | 141 | 8 | fb53be20392a8309a7393774c774a1b1aec6e676 | |
| ToppCell | facs|World / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.30e-06 | 172 | 141 | 7 | a2d0a64ebf09d219a07d6bbad1056bad6d46b9be | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.46e-06 | 175 | 141 | 7 | d52794426f2703a80e91ae0a8ff2d8e0ce4aa4a8 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.46e-06 | 175 | 141 | 7 | 454f03e6109d65f5db08dbb41ecc19ffb6bbc4e0 | |
| ToppCell | 390C-Fibroblasts-Fibroblast-B_(Myofibroblast)|390C / Donor, Lineage, Cell class and subclass (all cells) | 1.51e-06 | 176 | 141 | 7 | 852d3da0907fe87c0ef23d75a63ce07619cf0c54 | |
| ToppCell | 390C-Fibroblasts-Fibroblast-B_(Myofibroblast)-|390C / Donor, Lineage, Cell class and subclass (all cells) | 1.51e-06 | 176 | 141 | 7 | d2df1e435996c51213e88270af9f928e9e09a6f5 | |
| ToppCell | droplet-Lung-LUNG-30m-Endothelial-Artery_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.69e-06 | 179 | 141 | 7 | a09647750eba9d93c5efc1db3b555fefb5eec7b5 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.76e-06 | 180 | 141 | 7 | e8841ef1239f9ee73ac4f4e11faca0742694f368 | |
| ToppCell | facs-Lung-18m-Endothelial-arterial_endothelial|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.89e-06 | 182 | 141 | 7 | ebc812ed3f25839ea25f76b952c463d79a8325b1 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT_L6_FEZF2-Exc_L6_FEZF2_VWA2|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.89e-06 | 182 | 141 | 7 | 72e65a23cd36085bc880087d3cae92395de918a1 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT_L6_FEZF2|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.89e-06 | 182 | 141 | 7 | 05c167158815bf25d509df59ab386e1990712765 | |
| ToppCell | facs-Lung-18m-Endothelial-arterial_endothelial-pulmonary_artery_endothelial_cell|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.89e-06 | 182 | 141 | 7 | 47ff6b4002a4167412c79210651316d1342503f9 | |
| ToppCell | 3'-GW_trimst-1.5-SmallIntestine-Endothelial-lymphatic_endothelial-LEC4_(STAB2+)|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.96e-06 | 183 | 141 | 7 | a90ffd9c50caa65f537a2e441e37655e1b622327 | |
| ToppCell | 3'-GW_trimst-1.5-SmallIntestine-Endothelial-lymphatic_endothelial|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.96e-06 | 183 | 141 | 7 | 13ad20ec140ef5b96fdace3369b5befc0f40bb76 | |
| ToppCell | droplet-Lung-30m-Endothelial-arterial_endothelial-pulmonary_artery_endothelial_cell-pulmonary_artery_endothelial_cell_l27|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.96e-06 | 183 | 141 | 7 | 351d575339038bd4a66f408da518c567444208e8 | |
| ToppCell | Children_(3_yrs)-Endothelial-endothelial_cell_of_artery-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.11e-06 | 185 | 141 | 7 | a7ae76058b2082020cadec49d63b9f4e24d21734 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.34e-06 | 188 | 141 | 7 | b2d68a32314e9b099ed74d974079ad96359d1ae3 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.43e-06 | 189 | 141 | 7 | 032f169e8ede653117919bf97c17f92043320b3c | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.43e-06 | 189 | 141 | 7 | 07208d32afca6f93207a2ac35b647b31a9f71b7c | |
| ToppCell | frontal_cortex-Non-neuronal-leptomeningeal_cell-VLMC-VLMC_Spp1_Hs3st6|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 2.68e-06 | 123 | 141 | 6 | 64a2d7e40d9c948a9ccaf61c465fb2207e0b7ab8 | |
| ToppCell | Tracheal-10x5prime-Stromal-Peri/Epineurial_|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 3.19e-06 | 197 | 141 | 7 | 2cb1f557ce1400398975de94638126b4522567f3 | |
| ToppCell | Tracheal|World / Cell types per location group and 10X technology with lineage, and cell group designations | 3.53e-06 | 200 | 141 | 7 | 682960e28542a3d6c119047cd0131941932cfdea | |
| ToppCell | Control_saline-Endothelial-Endothelial|Control_saline / Treatment groups by lineage, cell group, cell type | 3.53e-06 | 200 | 141 | 7 | e77eba6172cabf85b8028638ed35299f2f079cd8 | |
| ToppCell | Bronchial-NucSeq-Stromal-Chondrocytic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.53e-06 | 200 | 141 | 7 | b7b9441fa7ab0d43741a2ebd5ec1a48d537c6d47 | |
| ToppCell | Control_saline-Endothelial|Control_saline / Treatment groups by lineage, cell group, cell type | 3.53e-06 | 200 | 141 | 7 | 3372c488a39fe812fa94e4f0564594186fea3db5 | |
| ToppCell | Bronchial-NucSeq-Stromal-Chondrocytic-Chondrocyte|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.53e-06 | 200 | 141 | 7 | 7c673ad0ea503ebd196579684d25d5f9e6a41030 | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Fibroblasts-Monocytes-Macrophages|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 8.73e-06 | 151 | 141 | 6 | f13a117ae26ae525da4f3e837d8f204d00dc6ee3 | |
| ToppCell | Adult-Mesenchymal-myofibroblast_cell-D122|Adult / Lineage, Cell type, age group and donor | 1.13e-05 | 158 | 141 | 6 | 410fa08c9d880d27e80ec939fa5ba5a41dcb31ab | |
| ToppCell | kidney_cells-Adult_normal_reference-Mesenchymal--glomerular_mesenchymal_cell-Renin-positive_Juxtaglomerular_Granular_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.30e-05 | 162 | 141 | 6 | c7114e24cb5525abb9780ca3d35dbcc4eabd4b64 | |
| ToppCell | kidney_cells-Adult_normal_reference-Mesenchymal--glomerular_mesenchymal_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.30e-05 | 162 | 141 | 6 | f1851a173d3bcca2981d934161ec85d1cc0af5a2 | |
| ToppCell | kidney_cells-Adult_normal_reference-Mesenchymal-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.30e-05 | 162 | 141 | 6 | 5d902bb31e691aea9749617cc88303c2448f24b8 | |
| ToppCell | frontal_cortex-Non-neuronal-leptomeningeal_cell-VLMC-VLMC_Osr1_Mc5r|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.60e-05 | 168 | 141 | 6 | 9930bd63b60c03f0152838a79eef77da1c2dd8e5 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal--glomerular_mesenchymal_cell-Renin-positive_Juxtaglomerular_Granular_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.71e-05 | 170 | 141 | 6 | 99dd734c0972a40d5381e8e2d96bdaa31f6d06e6 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal--glomerular_mesenchymal_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.71e-05 | 170 | 141 | 6 | 3a14eeae221b8bb0bd0dadcb8e7a603431240a1e | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.71e-05 | 170 | 141 | 6 | cdb6fad277f284c3fd5a6f45672a8edc24715882 | |
| ToppCell | frontal_cortex-Non-neuronal-leptomeningeal_cell|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.77e-05 | 171 | 141 | 6 | 2e43fb129ee9bdc3b31febc43c10f959bf0f4a7d | |
| ToppCell | frontal_cortex-Non-neuronal-leptomeningeal_cell-VLMC|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.77e-05 | 171 | 141 | 6 | e219a1aa59a96e4bc3e2eacf985679174a51de41 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT_L6_FEZF2-Exc_L5-6_FEZF2_ANKRD20A1|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.95e-05 | 174 | 141 | 6 | 99eb5e1aee136c7039e23b68a43a0fa3d775859f | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW19-Neuronal-Neuron|GW19 / Sample Type, Dataset, Time_group, and Cell type. | 2.02e-05 | 175 | 141 | 6 | 2812ac2ef41d245db544697fb6da1883361c96e8 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_3-Exc_L2-3_LINC00507_RPL9P17|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.29e-05 | 179 | 141 | 6 | 9ba8693fba2175bca9ff9735cc04e657abeb9084 | |
| ToppCell | wk_15-18-Endothelial-Blood_vessel_endothelial-OMD+_endo|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 2.29e-05 | 179 | 141 | 6 | 8c9ed247e1c4d655b81ce2f24a9936a7cade718a | |
| ToppCell | primary_visual_cortex-Non-neuronal-leptomeningeal_cell-VLMC-VLMC_Spp1_Hs3st6|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 2.32e-05 | 107 | 141 | 5 | 4a18261492371d19b8dbd403e197fdf64ef69392 | |
| ToppCell | E15.5-Mesenchymal-myocytic_cell-vascular_associated_smooth_muscle_cell|E15.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 2.36e-05 | 180 | 141 | 6 | 38035cf2c6fbc443ea10ca7e942572715ed572da | |
| ToppCell | droplet-Liver-hepatocytes-3m-Endothelial-endothelial_cell_of_hepatic_sinusoid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.44e-05 | 181 | 141 | 6 | 4df7972f88117108698efd06b124b232f8588981 | |
| ToppCell | facs-Lung-Endomucin_-18m-Endothelial-Artery_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.44e-05 | 181 | 141 | 6 | 4ea02344e1996f264dd5e14f3b19c8782ce41699 | |
| ToppCell | droplet-Liver-hepatocytes-3m-Endothelial|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.44e-05 | 181 | 141 | 6 | cbb530566893281289026bfd93adf721decd4ca3 | |
| ToppCell | Control-Epithelial-Basal|Control / Disease state, Lineage and Cell class | 2.52e-05 | 182 | 141 | 6 | caddd0a52f0234ea6a916186ffaf2454cdcd80ee | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Non-neuronal-Endothelial_Myeloid-Endo-Endothelial|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.59e-05 | 183 | 141 | 6 | 6cdadb3ece45a94a2915063aa461048e1d371ccd | |
| ToppCell | droplet-Kidney-KIDNEY-30m-Epithelial-Stroma____kidney_mesangial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.59e-05 | 183 | 141 | 6 | 8de4b616a06be03e1cb6ae6a9ce6bf06485629d3 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Non-neuronal-Endothelial_Myeloid-Endo-Endothelial-Endo_L2-5_CLDN5|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.59e-05 | 183 | 141 | 6 | 8714d3e7663c93cdf9b25b647353572e136f30c3 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Non-neuronal-Endothelial_Myeloid-Endo|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.59e-05 | 183 | 141 | 6 | c7fc96ac1d5d31ccefe0c1fc6ec76c7d8607a172 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_3-Exc_L2-3_LINC00507_RPL9P17|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.59e-05 | 183 | 141 | 6 | 1645d4a55cd8c22d6eb47fc5c6b1e576c454f111 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal-Myocytic_interstitial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 2.59e-05 | 183 | 141 | 6 | 667717366cb181b8a04a347e64f0f5a4dfc6ee7f | |
| ToppCell | COVID-19-Heart-EC_3|COVID-19 / Disease (COVID-19 only), tissue and cell type | 2.59e-05 | 183 | 141 | 6 | ff95382cfed592190d0636d2b750328471f82e0d | |
| ToppCell | droplet-Spleen-nan-24m-Lymphocytic-immature_NKT_cell|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.67e-05 | 184 | 141 | 6 | b998803180322a5ea2b567928dea531c26816c3c | |
| ToppCell | droplet-Lung-30m-Endothelial-arterial_endothelial-pulmonary_artery_endothelial_cell|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.67e-05 | 184 | 141 | 6 | f506d0ee48f39d6f59f19554217dfdf0987cc405 | |
| ToppCell | droplet-Lung-30m-Endothelial-arterial_endothelial|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.67e-05 | 184 | 141 | 6 | 8bcb1c4bc8ffef74338cdade926a94711de93c64 | |
| ToppCell | facs-Lung-24m-Mesenchymal-fibroblast-adventitial_fibroblast-adventitial_fibroblast_l17|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.67e-05 | 184 | 141 | 6 | d754c3de621429b220ae4ac426cdfc619e848462 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-chondrocyte-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 2.76e-05 | 185 | 141 | 6 | 8ed10ba581849c9c4ac4397226be2b62b4b3b900 | |
| ToppCell | droplet-Kidney-KIDNEY-30m-Epithelial-Pecam____Kidney_cortex_artery_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.76e-05 | 185 | 141 | 6 | f98af3146ec2f44c30d31a662fb9c4fa3ca4f706 | |
| ToppCell | facs-Heart-RV|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.76e-05 | 185 | 141 | 6 | 7cf2b0db059605032bfae60cf1b93c4c62608f0c | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal-Lung_smooth_muscle-MatrixFB_->_Myofibroblast|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.76e-05 | 185 | 141 | 6 | 3b2dfc8f4c87be516265dbecfc251276034d0efd | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-chondrocyte|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 2.76e-05 | 185 | 141 | 6 | b8052cebb73f41abe6faf0aa847be7c8ef23ae94 | |
| ToppCell | droplet-Lung-21m-Endothelial-arterial_endothelial-pulmonary_artery_endothelial_cell-pulmonary_artery_endothelial_cell_l27|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.84e-05 | 186 | 141 | 6 | c116cc9f41971622264434ebe29d18e719b0ae19 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Non-neuronal-Macroglial-Astro-Astrocyte|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.93e-05 | 187 | 141 | 6 | dd1d91f101b837bba513f77defa6e6902b2c0570 | |
| ToppCell | metastatic_Lymph_Node-Endothelial_cells-Tumor_ECs|metastatic_Lymph_Node / Location, Cell class and cell subclass | 2.93e-05 | 187 | 141 | 6 | 2713f526f86911fbbf6c7a3e69230f2e6bde31c3 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Non-neuronal-Macroglial-Astro|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.93e-05 | 187 | 141 | 6 | ae90c263f80c36a410150d499e268d198944a3d9 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.93e-05 | 187 | 141 | 6 | ec4b694487cc446999c7b27b119950a4f252c4b3 | |
| ToppCell | droplet-Lung-18m-Endothelial-arterial_endothelial|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.93e-05 | 187 | 141 | 6 | 12129e02638c20d9b7c1c6e512d48bfd966e1029 | |
| ToppCell | COVID-19-Heart-EC_2|Heart / Disease (COVID-19 only), tissue and cell type | 2.93e-05 | 187 | 141 | 6 | 40ffc06a3e3251d9b12da390210d3e045af7537a | |
| ToppCell | droplet-Lung-18m-Endothelial-arterial_endothelial-pulmonary_artery_endothelial_cell|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.93e-05 | 187 | 141 | 6 | 83930ef55191eff9006113feaeabb3c2fa21fd05 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.93e-05 | 187 | 141 | 6 | 530e4e6d91b5c0d9aa4543caa2b734a1674c5788 | |
| ToppCell | Control-Fibroblasts-Other_FB|Control / group, cell type (main and fine annotations) | 2.93e-05 | 187 | 141 | 6 | bd3739c4a52aa1ba5deffd778e113a9800f7e158 | |
| ToppCell | droplet-Liver-LIVER_NPC-30m-Endothelial-endothelial_cell_of_hepatic_sinusoid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.02e-05 | 188 | 141 | 6 | 0aa8747c2931b0c91f6d78bb2db8fd8ede6dd559 | |
| ToppCell | -Unknown-Endothelial-Myofibroblast| / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.02e-05 | 188 | 141 | 6 | 6468fa95ad0395395301115286f2d8c0df5d3882 | |
| ToppCell | -Unknown-Endothelial| / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.02e-05 | 188 | 141 | 6 | 7a81ac5c79c3eb26639b52d2b9fd5e7ef9798fd6 | |
| ToppCell | -Unknown| / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.02e-05 | 188 | 141 | 6 | 9cb718bfe1358c6fd842f096e228eb0abb9aefc6 | |
| ToppCell | droplet-Kidney-nan-18m-Epithelial-kidney_mesangial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.02e-05 | 188 | 141 | 6 | d1a4cd4db95d8d32b79156290f7867f32824cc87 | |
| ToppCell | Mesenchymal-chondrocyte|World / Lineage, Cell type, age group and donor | 3.02e-05 | 188 | 141 | 6 | 7b1e3f8a941eaa68e89c562129a92314642eec66 | |
| ToppCell | human_hepatoblastoma-Tumor_cells-T5|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells) | 3.02e-05 | 188 | 141 | 6 | b070a0667f1ee9b825b267b6c389b7c42fc436f9 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.11e-05 | 189 | 141 | 6 | 7fbe855bfdb47d35e040b04a80fe4b729a3764e8 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.11e-05 | 189 | 141 | 6 | 06b35abecd29f902cf251fcc1f6ad33db7ab08a2 | |
| ToppCell | facs-Heart-LV-3m-Endothelial|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.11e-05 | 189 | 141 | 6 | d424d2554595b2304219f7324406b401711af7c2 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.11e-05 | 189 | 141 | 6 | 127ad2ba3e794df8cce2eee3e4171bccb5aad51b | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.11e-05 | 189 | 141 | 6 | 2cfb4d12f75678d1619f4743838a0e954bd57761 | |
| ToppCell | facs-Heart-LV-3m-Endothelial-endothelial_cell_of_coronary_artery|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.11e-05 | 189 | 141 | 6 | 393ec5954a12d6cf67bb435dcc34ff0b14c81e9f | |
| ToppCell | facs-Heart-LV-3m-Endothelial-coronary_vascular_endothelial_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.11e-05 | 189 | 141 | 6 | bec57459ad4bab15b2532b57722549fec2e771fb | |
| ToppCell | Control-Stromal_mesenchymal-Lung_smooth_muscle|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.11e-05 | 189 | 141 | 6 | 45e588b2a4ad9e3ff74e22d9d627ed3571f3b8b8 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Afferent_/_Efferent_Arteriole_Endothelial_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.20e-05 | 190 | 141 | 6 | bf9bc57a605c7e3979bc4f7260e6fb92c3eb8690 | |
| ToppCell | droplet-Liver-LIVER_NPC-30m-Endothelial-endothelial_cell_of_hepatic_sinusoid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.20e-05 | 190 | 141 | 6 | a08c5929b05a4969852e351a93c4e4deb4c8d5b6 | |
| ToppCell | Somatosensory_Cortex_(S1)-Non-neuronal-Macroglial-Astro|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.20e-05 | 190 | 141 | 6 | 3a55cc5dc2549788bfe55f649686887b21a1fdd2 | |
| ToppCell | facs-Heart-RV-3m-Endothelial-endothelial_cell_of_coronary_artery|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.20e-05 | 190 | 141 | 6 | 89d1d686cc683206534e2157554d7d0df5d53497 | |
| ToppCell | COVID-19-kidney-AQP1+SLC14A1+EC|kidney / Disease (COVID-19 only), tissue and cell type | 3.20e-05 | 190 | 141 | 6 | 1519f34d31fe0817184c5865a0bc9f0cb479b1a4 | |
| ToppCell | facs-Heart-RV-3m-Endothelial-coronary_vascular_endothelial_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.20e-05 | 190 | 141 | 6 | 65ba6c4f4a2905c0bf4ff99518ae49e3dfd5e640 | |
| ToppCell | droplet-Liver-LIVER_NPC-30m-Endothelial|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.20e-05 | 190 | 141 | 6 | 25525fee1da8a808034d9c916159fd0b6b26bce8 | |
| ToppCell | 10x3'2.3-week_12-13-Lymphocytic_B-B_lineage-pro_B_progenitor|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 3.20e-05 | 190 | 141 | 6 | f623f0bdece6002b68ac2207e99408b24a2b1194 | |
| ToppCell | COVID-19-Heart-EC_3|Heart / Disease (COVID-19 only), tissue and cell type | 3.20e-05 | 190 | 141 | 6 | 78e7c502b0450c0b37652b1896a2a752fd8a2111 | |
| Drug | DNA-PK Inhibitor III; Up 200; 1uM; PC3; HT_HG-U133A | PDE4A ZNF318 PTPRU ADAM8 ITGB4 KLHL22 BMP7 CELSR2 BAIAP2 OSMR | 4.07e-07 | 200 | 138 | 10 | 7518_UP |
| Drug | irinotecan HCl; Down 200; 100uM; MCF7; HT_HG-U133A | 1.19e-06 | 174 | 138 | 9 | 7530_DN | |
| Drug | Cephapirin sodium salt [24356-60-3]; Down 200; 9uM; PC3; HT_HG-U133A | 3.18e-06 | 196 | 138 | 9 | 7142_DN | |
| Drug | KS24 | 4.30e-06 | 6 | 138 | 3 | CID000099135 | |
| Drug | Raloxifene Hydrochloride | SEMA4B RB1 DOCK9 POLR2B CLSTN1 GDF9 F8 RND3 BMP7 TAOK3 CLCN6 MICAL2 ENTPD2 C3 CAP2 TNS3 KPNA2 | 1.76e-05 | 857 | 138 | 17 | ctd:D020849 |
| Drug | Trimeprazine tartrate [4330-99-8]; Up 200; 5.4uM; MCF7; HT_HG-U133A | 2.57e-05 | 195 | 138 | 8 | 3478_UP | |
| Drug | Mesoridazine besylate [32672-69-8]; Down 200; 7.4uM; MCF7; HT_HG-U133A | 2.67e-05 | 196 | 138 | 8 | 2874_DN | |
| Drug | Fluoxetine hydrochloride [59333-67-4]; Up 200; 11.6uM; MCF7; HT_HG-U133A | 2.67e-05 | 196 | 138 | 8 | 3314_UP | |
| Drug | Nalbuphine hydrochloride [23277-43-2]; Up 200; 10.2uM; PC3; HT_HG-U133A | 2.67e-05 | 196 | 138 | 8 | 2063_UP | |
| Drug | LY 294002; Down 200; 10uM; HL60; HT_HG-U133A | 2.67e-05 | 196 | 138 | 8 | 2687_DN | |
| Drug | Lithocholic acid [434-13-9]; Down 200; 10.6uM; PC3; HT_HG-U133A | 2.67e-05 | 196 | 138 | 8 | 3816_DN | |
| Drug | rosiglitazone; Up 200; 10uM; MCF7; HT_HG-U133A_EA | 2.77e-05 | 197 | 138 | 8 | 1071_UP | |
| Drug | Harmalol hydrochloride dihydrate [6028-07-5]; Up 200; 14.6uM; MCF7; HT_HG-U133A | 2.77e-05 | 197 | 138 | 8 | 5495_UP | |
| Drug | Xylazine [7361-61-7]; Down 200; 18.2uM; PC3; HT_HG-U133A | 2.77e-05 | 197 | 138 | 8 | 4066_DN | |
| Drug | Cloperastine hydrochloride [14984-68-0]; Down 200; 11uM; MCF7; HT_HG-U133A | 2.77e-05 | 197 | 138 | 8 | 4732_DN | |
| Drug | Thioproperazine dimesylate [2347-80-0]; Up 200; 6.2uM; HL60; HG-U133A | 2.98e-05 | 199 | 138 | 8 | 1390_UP | |
| Drug | octestrol | 3.65e-05 | 2 | 138 | 2 | CID000006827 | |
| Disease | autism spectrum disorder (implicated_via_orthology) | 6.37e-06 | 152 | 134 | 7 | DOID:0060041 (implicated_via_orthology) | |
| Disease | complement C3B measurement | 2.05e-05 | 2 | 134 | 2 | EFO_0020275 | |
| Disease | intellectual disability (implicated_via_orthology) | 2.40e-05 | 75 | 134 | 5 | DOID:1059 (implicated_via_orthology) | |
| Disease | autism spectrum disorder (is_implicated_in) | 4.91e-05 | 16 | 134 | 3 | DOID:0060041 (is_implicated_in) | |
| Disease | complement C3D fragment measurement | 6.12e-05 | 3 | 134 | 2 | EFO_0020277 | |
| Disease | complement C3 measurement | 6.12e-05 | 3 | 134 | 2 | EFO_0004983 | |
| Disease | neuroticism measurement | HIVEP1 MARCHF10 PKP4 DYRK1A HPSE2 QRICH1 IL1RAPL1 ORC4 TAOK3 MICAL2 ASXL3 PKHD1 BAIAP2 SPATS2 | 7.01e-05 | 909 | 134 | 14 | EFO_0007660 |
| Disease | v-set and transmembrane domain-containing protein 4 measurement | 3.03e-04 | 6 | 134 | 2 | EFO_0803247 | |
| Disease | response to allopurinol, uric acid measurement | 4.12e-04 | 32 | 134 | 3 | EFO_0004761, EFO_0006337 | |
| Disease | vascular cell adhesion protein 1 measurement | 4.24e-04 | 7 | 134 | 2 | EFO_0020846 | |
| Disease | bifunctional heparan sulfate N-deacetylase/N-sulfotransferase 1 measurement | 4.24e-04 | 7 | 134 | 2 | EFO_0802332 | |
| Disease | regulator of G-protein signaling 8 measurement | 4.24e-04 | 7 | 134 | 2 | EFO_0801997 | |
| Disease | glycosyl ceramide (d18:1/20:0, d16:1/22:0) measurement | 4.24e-04 | 7 | 134 | 2 | EFO_0800551 | |
| Disease | glycosyl-N-behenoyl-sphingadienine (d18:2/22:0) measurement | 4.24e-04 | 7 | 134 | 2 | EFO_0800520 | |
| Disease | alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase 2 measurement | 5.63e-04 | 8 | 134 | 2 | EFO_0801373 | |
| Disease | calcium/calmodulin-dependent protein kinase type 1D measurement | 5.63e-04 | 8 | 134 | 2 | EFO_0008063 | |
| Disease | atypical hemolytic-uremic syndrome (is_implicated_in) | 5.63e-04 | 8 | 134 | 2 | DOID:0080301 (is_implicated_in) | |
| Disease | Atypical hemolytic-uremic syndrome | 7.22e-04 | 9 | 134 | 2 | cv:C2931788 | |
| Disease | cellular retinoic acid-binding protein 1 measurement | 7.22e-04 | 9 | 134 | 2 | EFO_0801463 | |
| Disease | tumor necrosis factor ligand superfamily member 14 measurement | 7.22e-04 | 9 | 134 | 2 | EFO_0010613 | |
| Disease | 22q11 partial monosomy syndrome | 7.22e-04 | 9 | 134 | 2 | C3266101 | |
| Disease | C3 glomerulopathy | 7.22e-04 | 9 | 134 | 2 | C4087273 | |
| Disease | Hemolytic-uremic syndrome | 7.22e-04 | 9 | 134 | 2 | cv:C0019061 | |
| Disease | RNA-binding protein 24 measurement | 7.22e-04 | 9 | 134 | 2 | EFO_0802030 | |
| Disease | ceramide measurement | 7.36e-04 | 235 | 134 | 6 | EFO_0010222 | |
| Disease | DNA-directed RNA polymerases I and III subunit RPAC1 measurement | 8.99e-04 | 10 | 134 | 2 | EFO_0801535 | |
| Disease | Atypical Hemolytic Uremic Syndrome | 8.99e-04 | 10 | 134 | 2 | C2931788 | |
| Disease | bone morphogenetic protein 7 measurement | 8.99e-04 | 10 | 134 | 2 | EFO_0020187 | |
| Disease | OCIA domain-containing protein 1 measurement | 8.99e-04 | 10 | 134 | 2 | EFO_0008252 | |
| Disease | Marfan syndrome (implicated_via_orthology) | 8.99e-04 | 10 | 134 | 2 | DOID:14323 (implicated_via_orthology) | |
| Disease | Asymmetric crying face association | 8.99e-04 | 10 | 134 | 2 | C0431406 | |
| Disease | C-C motif chemokine 21 measurement | 8.99e-04 | 10 | 134 | 2 | EFO_0008048 | |
| Disease | pneumonia (implicated_via_orthology) | 8.99e-04 | 10 | 134 | 2 | DOID:552 (implicated_via_orthology) | |
| Disease | 22q11 Deletion Syndrome | 8.99e-04 | 10 | 134 | 2 | C2936346 | |
| Disease | gastrin-releasing peptide measurement | 1.10e-03 | 11 | 134 | 2 | EFO_0022000 | |
| Disease | Autistic Disorder | 1.26e-03 | 261 | 134 | 6 | C0004352 | |
| Disease | congenital diaphragmatic hernia (implicated_via_orthology) | 1.31e-03 | 12 | 134 | 2 | DOID:3827 (implicated_via_orthology) | |
| Disease | vascular endothelial growth factor A measurement | 1.31e-03 | 12 | 134 | 2 | EFO_0010804 | |
| Disease | oncostatin-M measurement | 1.31e-03 | 12 | 134 | 2 | EFO_0010792 | |
| Disease | tyrosine-protein kinase ZAP-70 measurement | 1.31e-03 | 12 | 134 | 2 | EFO_0020833 | |
| Disease | triglycerides to total lipids in medium LDL percentage | 1.54e-03 | 50 | 134 | 3 | EFO_0022334 | |
| Disease | triglycerides to total lipids in large LDL percentage | 1.63e-03 | 51 | 134 | 3 | EFO_0022331 | |
| Disease | membranous glomerulonephritis (biomarker_via_orthology) | 1.80e-03 | 14 | 134 | 2 | DOID:10976 (biomarker_via_orthology) | |
| Disease | wet macular degeneration | 1.80e-03 | 14 | 134 | 2 | EFO_0004683 | |
| Disease | C-C motif chemokine 19 measurement | 1.80e-03 | 14 | 134 | 2 | EFO_0008047 | |
| Disease | osteoarthritis (implicated_via_orthology) | 2.07e-03 | 15 | 134 | 2 | DOID:8398 (implicated_via_orthology) | |
| Disease | DiGeorge Syndrome | 2.36e-03 | 16 | 134 | 2 | C0012236 | |
| Disease | Shprintzen syndrome | 2.36e-03 | 16 | 134 | 2 | C0220704 | |
| Disease | CONOTRUNCAL ANOMALY FACE SYNDROME | 2.36e-03 | 16 | 134 | 2 | C0795907 | |
| Disease | Astrocytosis | 2.66e-03 | 17 | 134 | 2 | C3887640 | |
| Disease | Antibody Deficiency Syndrome | 2.66e-03 | 17 | 134 | 2 | C0003257 | |
| Disease | Gliosis | 2.66e-03 | 17 | 134 | 2 | C0017639 | |
| Disease | response to bronchodilator, FEV/FEC ratio | 2.67e-03 | 766 | 134 | 10 | EFO_0004713, GO_0097366 | |
| Disease | triglycerides:total lipids ratio, intermediate density lipoprotein measurement | 2.73e-03 | 127 | 134 | 4 | EFO_0008595, EFO_0020947 | |
| Disease | renal cell carcinoma (is_marker_for) | 2.81e-03 | 128 | 134 | 4 | DOID:4450 (is_marker_for) | |
| Disease | bipolar disorder, sex interaction measurement | 2.99e-03 | 18 | 134 | 2 | EFO_0008343, MONDO_0004985 | |
| Disease | Age-related macular degeneration | 2.99e-03 | 18 | 134 | 2 | cv:C0242383 | |
| Disease | obesity (implicated_via_orthology) | 3.06e-03 | 215 | 134 | 5 | DOID:9970 (implicated_via_orthology) | |
| Disease | carcinoma (implicated_via_orthology) | 3.12e-03 | 64 | 134 | 3 | DOID:305 (implicated_via_orthology) | |
| Disease | depressive symptom measurement | 3.40e-03 | 426 | 134 | 7 | EFO_0007006 | |
| Disease | alpha-tocopherol measurement | 3.69e-03 | 20 | 134 | 2 | EFO_0007898 | |
| Disease | Abdominal Aortic Aneurysm | 3.70e-03 | 68 | 134 | 3 | EFO_0004214 | |
| Disease | myeloid white cell count | NRIP1 DNAJC13 SETD1B DYRK1A QRICH1 ITGA4 PCGF3 JMJD1C MICAL2 C3 TNS3 | 3.72e-03 | 937 | 134 | 11 | EFO_0007988 |
| Disease | COVID-19 (is_implicated_in) | 4.06e-03 | 21 | 134 | 2 | DOID:0080600 (is_implicated_in) | |
| Disease | gastric ulcer | 4.06e-03 | 21 | 134 | 2 | EFO_0009454 | |
| Disease | cholesterol:total lipids ratio, low density lipoprotein cholesterol measurement | 4.28e-03 | 144 | 134 | 4 | EFO_0004611, EFO_0020943 | |
| Disease | Agents acting on the renin-angiotensin system use measurement | 4.36e-03 | 335 | 134 | 6 | EFO_0009931 | |
| Disease | wellbeing measurement | 4.43e-03 | 692 | 134 | 9 | EFO_0007869 | |
| Disease | seminoma (is_marker_for) | 4.46e-03 | 22 | 134 | 2 | DOID:4440 (is_marker_for) | |
| Disease | nephrosis (biomarker_via_orthology) | 4.46e-03 | 22 | 134 | 2 | DOID:2527 (biomarker_via_orthology) |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| MLQHQFPSVQANAAA | 536 | Q99569 | |
| SSTFNRVNANMSHPL | 506 | A8K979 | |
| NYQFAVRAMNSHGPS | 211 | Q63HQ2 | |
| ISLVSFNSRPDGMHQ | 456 | Q9UPQ3 | |
| SPGDFRTNMNVVHQN | 151 | Q6ULP2 | |
| SYTIIQQMPRGNHFT | 1456 | Q6V0I7 | |
| SRFQLFMQEAESHPQ | 851 | O15085 | |
| NHMGNVTFTIPANRE | 81 | P01024 | |
| NPVSALHQFAQMQRV | 96 | Q96M93 | |
| QIPNSHNMTTTLNYR | 816 | P08603 | |
| QEMANPQHFLGSSLV | 1611 | Q9HCU4 | |
| AMQHISYLNSRQFPT | 601 | O94985 | |
| AGQMPHSHQYSDRRQ | 31 | Q13627 | |
| MGRSNPLFHQAASRV | 696 | P78325 | |
| PLNSYMNATNHAIVQ | 366 | P18075 | |
| TFGNMNNAVRPVFAH | 246 | Q14156 | |
| MRAAAQPQAVASTHA | 396 | Q5H9R4 | |
| TDAGTSHRQQFYQMP | 1921 | Q9C0F0 | |
| SHRQQFYQMPVAARG | 1926 | Q9C0F0 | |
| LQNNHTAADMYLSPV | 596 | P06400 | |
| QSHPLQYIGHDRTMQ | 61 | Q3KNV8 | |
| NLTHRVYLMNPFSVN | 326 | Q99650 | |
| NSLFPAQFMNGNIHI | 381 | Q2TAL8 | |
| INYPESHRLGSMVNQ | 806 | Q8HWS3 | |
| HFVHMRGLPFQANAQ | 401 | Q12849 | |
| PSNDSRQMHQALQDF | 436 | Q9UM07 | |
| SHRQIHLMNSFGFPQ | 211 | O43929 | |
| NLRDNHPLQFMEFSS | 26 | Q86T65 | |
| PHSMNSRVFIGNLNT | 11 | O60812 | |
| MFSSVAHLARANPFN | 1 | Q00325 | |
| VRYHNNLAAQPVMQT | 271 | Q8N4N3 | |
| RMNTAFTPFLHQRNG | 221 | Q8NFG4 | |
| YVPHRQNNSTRNKGM | 471 | Q9NQ76 | |
| PNNMQVLYTALQHSS | 456 | Q8N201 | |
| VPNRNSHNMELYNIS | 411 | O95835 | |
| GQVNNAAASPLHMLA | 591 | Q01167 | |
| PHSMNSRVFIGNLNT | 11 | B7ZW38 | |
| VYFSHNPAGTSVQNM | 246 | Q5W064 | |
| MYTQRVQQILASHNP | 241 | Q5FYB0 | |
| FAPRNSNTMAAAALA | 186 | A6ND91 | |
| HYTRAQANSPRPAMN | 276 | Q15652 | |
| RAFLLMASQYQQPHE | 86 | P40123 | |
| MAQRPQNFNSSARVS | 286 | Q9Y5L3 | |
| QHTYCNIPMTLINGQ | 646 | Q9NZN1 | |
| QGPHARYNMNDAIFS | 351 | O75564 | |
| LMHSNSLNNSNIPRF | 341 | P27815 | |
| HRGTNNLYQMKSQNP | 601 | P35913 | |
| MPANHQTFLRQRTFS | 981 | Q32MH5 | |
| AYNQTIMPNLLGHTN | 51 | Q14332 | |
| SFRINIPGNMAHSSQ | 776 | Q9P1Y6 | |
| NPISIFMTHLSNYGN | 521 | P52848 | |
| ANTEPRANLHMNLYE | 646 | Q0VF49 | |
| LRSPYNSHMGNNASR | 1121 | P48552 | |
| TSPENMHRNVAQYGL | 446 | Q8TDZ2 | |
| ADHYSQQMAQQLRLP | 346 | Q96PP9 | |
| PHSMNSRVFIGNLNT | 11 | P0DMR1 | |
| SNNSLSEMTHFRPQL | 846 | P00451 | |
| IYMNLASHIQPGTVN | 316 | Q8WXI9 | |
| NPISIFMTHLSNYGN | 511 | Q9H3R1 | |
| NEPNNYRTMHGRAVN | 261 | Q8WWQ2 | |
| NNMQRPGFATHAASI | 796 | P16144 | |
| HPEAEMAQNSVRLNY | 466 | P14923 | |
| MQQPQISVYSGSDRH | 31 | Q8NDX5 | |
| GYFMTAVPQTQNHAA | 401 | Q9H361 | |
| MQYVNGAATTHQLPV | 711 | Q6VY07 | |
| YLMVNTSQHAPGQRA | 71 | Q92729 | |
| FTQATQLSRHQRMPN | 566 | Q9NQX0 | |
| MSTNENANTPAARLH | 1 | P52292 | |
| TPLRKRYNSHQMGQS | 646 | Q6PIJ6 | |
| NPAASDFHLQAMIQS | 1166 | Q3L8U1 | |
| MAHSRTSTPLLQQYQ | 2006 | Q3L8U1 | |
| PNTHVSQVFNLFRTM | 816 | P51797 | |
| ASALMYHRNESLQPS | 271 | Q53GT1 | |
| NHFSVRQMLATTSPA | 421 | Q9BZ29 | |
| KSRINIYQRNAPNHM | 1486 | Q9H799 | |
| NPGMYQHRTVIADQF | 176 | Q9HCG7 | |
| YSNSSVRNELPMHHN | 541 | Q03188 | |
| NCMQANPHYARVIGT | 421 | Q9H336 | |
| FVQMANLSPAHQARS | 656 | Q68DX3 | |
| PAMDAAGIHLRQFSN | 376 | Q6PGQ7 | |
| FLLFRGHNSQPTMTQ | 16 | Q19T08 | |
| SFPLNAHMNATNHAI | 446 | P22004 | |
| AMISSLSQNHPDNRN | 146 | Q9UBX1 | |
| NNLDHPSVFMQTRFV | 861 | Q9Y5Q5 | |
| DMFCNSTHPQVRAQT | 1861 | O75165 | |
| VSHFPNQNDNGSRMA | 606 | Q8NA82 | |
| NLTFHVINTGNSMAP | 806 | P13612 | |
| MPNLLNHYDQQTAAL | 46 | Q9NPG1 | |
| RSGFSVAMAPNHQTL | 296 | Q8TBB5 | |
| HPSAQNGLFNMTLVS | 246 | O60383 | |
| YMRSLNNFRAEQPHQ | 666 | P14735 | |
| YLVSAHAMNNSGPTA | 236 | P54198 | |
| QFPQMTVSSLQCNRH | 336 | Q13002 | |
| RGRQHSVFQSMLQNF | 746 | Q6ZVF9 | |
| LIMTSDYQRSNPHAA | 416 | P49336 | |
| ILMNSSRDNSHPFVG | 341 | Q96RP9 | |
| GEMTEVLPNQRYNSH | 331 | O76054 | |
| MASHNTLQNFTAAIP | 31 | Q4U2R8 | |
| LHQSLPQNQCYMATT | 256 | Q9H9B1 | |
| TQRNPNARKGMASHT | 576 | Q9BV36 | |
| ATNYQLPSLDFAMNH | 346 | O94851 | |
| MNPANHSQVAGFVLL | 1 | Q8NGN0 | |
| NHRQTPVSYDQGANM | 151 | P61587 | |
| MSHLSQQRIYSGENP | 1 | Q15072 | |
| SFHAYNRMTPQNLAV | 541 | Q6ZW31 | |
| RMGFPQHTIASLSDQ | 251 | Q6P1K8 | |
| GMQARAPSQYSTRHF | 181 | Q8N4H0 | |
| SIIHNFRANNVSPMT | 131 | Q15147 | |
| GTVIAYRQRQHQDMP | 756 | Q9UBV2 | |
| SPASLYQQNQVMHLS | 921 | Q8NE09 | |
| RNFYDPTSAMVLQQH | 341 | Q8TC59 | |
| NTANLSPDHMQRLTF | 911 | Q8TC59 | |
| YAASHSGVVQVPMAN | 511 | Q9NPR2 | |
| HNQSPRNTYQSAMGK | 716 | P30876 | |
| AMSALYHIAQNDSPT | 226 | Q9H2K8 | |
| DGQHFSLAMSSNRPV | 51 | Q9UPS6 | |
| PIFGDMLATANQHTQ | 891 | P08F94 | |
| PVQRHVTMSTNNRFS | 176 | Q8NHU6 | |
| RQQQMVVAHQYSFAP | 591 | Q68CZ2 | |
| NQIAAAFGHMPLLSS | 636 | Q92935 | |
| GARSMSRNPFAHVQL | 506 | Q9UQB8 | |
| VVNNMNRTALHFAVG | 96 | A6NHY2 | |
| NNISRILVTSFNHMP | 191 | O75094 | |
| LGHFQENMQIQSFPR | 801 | Q96JI7 | |
| YMQRASDLARQINHP | 301 | Q6DKK2 | |
| LTMHSIHNSQQPRNA | 191 | Q86XZ4 | |
| DQMPARSLSRGFNNH | 586 | Q8NBP0 | |
| ASRDSQMQNPYSRHS | 491 | Q9H3R2 | |
| LHNISPQMSAAAAAA | 396 | Q04727 | |
| IPGMNTRDQYATITH | 331 | Q9NXZ1 | |
| SAMSPRDLYATINHN | 201 | A6NJ88 | |
| RMGFPQHTIASLSDQ | 251 | Q13888 | |
| NQRVGETFHASQPSM | 241 | P84022 | |
| YENMRFLITHNPTNA | 11 | Q12974 | |
| ANMNRLFFQPHQAGL | 111 | Q9GZZ9 | |
| PHIRSMANQLIQFNT | 606 | Q8WWQ8 | |
| TSAIPQYHLAMSNGT | 326 | O95789 | |
| VSLPGSQQHLSANMF | 371 | Q8TEC5 | |
| SFVPTNMAVNYVQHN | 211 | Q9NZ63 | |
| QFVSQLPHMQAARGS | 336 | Q96AX1 | |
| FINVMLSHPNHTGNN | 266 | Q5HYJ1 | |
| PDRQGQSSHYSQMDR | 526 | Q6XPR3 | |
| MSSLQPEASARGHFQ | 1561 | Q702N8 | |
| AALSQFHMPRASQFA | 756 | Q5VUA4 | |
| MPIYNSTHVASVVNQ | 371 | P15822 | |
| PNESNLTQLYMHLTN | 236 | Q6ZT98 | |
| RSYDFIMPNSSVHNN | 436 | Q9C0D4 |